Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Price to Book Ratio 2015–2026
Price to book (P/B) ratio for Aclaris Therapeutics, Inc. (ACRS): market cap divided by shareholder equity. As of March 31, 2026 it is 4.69.
From: 03/31/2018To: 03/31/2026
Stock Price
Book Value
Price to Book
Aclaris Therapeutics, Inc. Price to Book Ratio — FAQ
Aclaris Therapeutics, Inc. (ACRS) price to book ratio over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's price to book ratio history?
The chart and table above show Aclaris Therapeutics, Inc.'s price to book ratio by year and by quarter, including the growth rate.